Page last updated: 2024-08-25

zoledronic acid and Musculoskeletal Diseases

zoledronic acid has been researched along with Musculoskeletal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardia, A; Blackford, AL; Connolly, RM; Fetting, JH; Hayes, DF; Henry, NL; Jeter, SC; Miller, RS; Nguyen, A; Quinlan, K; Rosner, GL; Santa-Maria, CA; Slater, S; Snyder, C; Stearns, V; Storniolo, AM; Wolff, AC; Zorzi, J1
He, W; Liu, XA; Yang, T; Zhang, PL; Zhou, WB1

Reviews

1 review(s) available for zoledronic acid and Musculoskeletal Diseases

ArticleYear
Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis.
    Journal of experimental & clinical cancer research : CR, 2011, Aug-04, Volume: 30

    Topics: Breast Neoplasms; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Musculoskeletal Diseases; Randomized Controlled Trials as Topic; Zoledronic Acid

2011

Trials

1 trial(s) available for zoledronic acid and Musculoskeletal Diseases

ArticleYear
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
    Breast cancer research and treatment, 2018, Volume: 171, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Middle Aged; Musculoskeletal Diseases; Odds Ratio; Proportional Hazards Models; Treatment Outcome; Zoledronic Acid

2018